APA (7th ed.) Citation

Okada, N., Niimura, T., Zamami, Y., Hamano, H., Ishida, S., Goda, M., . . . Ishizawa, K. (2019). Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database. Cancer medicine (Malden, MA), 8(1), 174-181. https://doi.org/10.1002/cam4.1920

Chicago Style (17th ed.) Citation

Okada, Naoto, et al. "Pharmacovigilance Evaluation of the Relationship Between Impaired Glucose Metabolism and BCR‐ABL Inhibitor Use by Using an Adverse Drug Event Reporting Database." Cancer Medicine (Malden, MA) 8, no. 1 (2019): 174-181. https://doi.org/10.1002/cam4.1920.

MLA (9th ed.) Citation

Okada, Naoto, et al. "Pharmacovigilance Evaluation of the Relationship Between Impaired Glucose Metabolism and BCR‐ABL Inhibitor Use by Using an Adverse Drug Event Reporting Database." Cancer Medicine (Malden, MA), vol. 8, no. 1, 2019, pp. 174-181, https://doi.org/10.1002/cam4.1920.